Drug profile · INN
adalimumab-bwwd
HADLIMA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
adalimumab-bwwd (HADLIMA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN adalimumab-bwwd
Brand HADLIMA
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is adalimumab-bwwd?
adalimumab-bwwd (HADLIMA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for adalimumab-bwwd?
HADLIMA is a marketed brand name for adalimumab-bwwd. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of adalimumab-bwwd?
adalimumab-bwwd has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.